Co-Diagnostics CODX Income Statement (2016-2026)

NASDAQ CODX
$0.26 -0.01 (-3.70%)
At close: Nov 13, 2026 · 4:00 PM EST
Reported Financials

Co-Diagnostics Quarterly Income Statement

Periods 42 quarters
Latest Sep 2026

Co-Diagnostics reported revenue of $0.28M and net income of -$6.31M for the quarter ended Sep 2026, up 94.6% year over year. This income statement covers 42 quarters of results from Jun 2016 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Revenue & cost
Revenue
20.40M22.70M5.02M5.09M1.40M0.60M0.20M2.46M3.56M0.47M2.66M0.64M0.15M0.05M0.16M0.15M0.26M0.15M0.17M0.28M
Cost of RevenueCost of Rev
2.49M3.28M0.92M0.77M0.52M0.50M0.46M0.26M2.97M0.23M0.21M0.30M0.26M0.02M0.03M0.03M0.14M0.19M0.05M0.30M
Gross Profit
17.91M19.42M4.11M4.33M0.89M0.10M-0.26M2.20M0.59M0.23M2.44M0.34M-0.11M0.03M0.13M0.12M0.12M-0.05M0.12M-0.02M
Operating items
Research & DevelopmentR&D
2.18M3.77M3.89M5.04M4.74M5.01M5.98M5.79M6.18M5.68M5.61M4.88M4.81M4.87M4.69M4.48M5.10M5.93M4.15M3.57M
Selling, General & AdministrativeSG&A
3.23M2.92M2.47M3.62M5.25M3.01M3.71M3.15M4.40M2.92M3.13M4.29M5.82M2.77M2.60M1.82M1.87M2.50M1.50M1.87M
Other Operating ExpensesOther Opex
2.20M2.90M1.90M2.20M17.02M2.02M2.04M2.20M1.83M1.89M1.38M1.41M1.18M0.94M0.90M0.84M19.70M0.72M0.67M0.80M
Operating ExpensesOpex
7.61M9.59M8.25M10.86M27.01M10.05M11.73M11.14M12.41M10.49M10.12M10.58M11.80M8.58M8.19M7.13M26.66M9.16M6.32M6.25M
Operating IncomeOp. Inc
10.31M9.82M-4.15M-6.54M-26.12M-9.95M-11.99M-8.94M-11.83M-10.26M-7.68M-10.23M-11.91M-8.55M-8.06M-7.01M-26.54M-9.21M-6.20M-6.27M
Non-operating items
Non Operating Interest Expenses
Gains (Losses) on Sale of Assets & InvestmentsGains on Sales
0.36M-0.09M-0.05M0.00M0.42M0.41M0.43M0.99M0.23M0.07M0.29M0.28M0.30M0.34M0.04M
Interest & Investment IncomeInt & Inv Inc
0.01M0.01M0.06M0.30M0.33M0.20M0.19M0.32M0.44M0.36M0.34M0.26M0.12M0.01M0.01M0.01M0.25M0.01M0.02M0.00M
Other Non Operating IncomeOther Non Op Inc.
Non Operating IncomeNon Op. Inc.
-0.06M3.28M0.72M3.06M1.08M1.94M0.84M0.84M0.98M0.97M0.10M0.56M0.87M1.03M0.34M-0.04M0.32M0.07M-0.06M-0.04M
Net income details
EBIT
10.31M9.82M-4.15M-6.54M-26.12M-9.95M-11.99M-8.94M-11.83M-10.26M-7.68M-10.23M-11.91M-8.55M-8.06M-7.01M-26.54M-9.21M-6.20M-6.27M
EBT
10.24M13.10M-3.43M-3.48M-25.04M-8.02M-11.16M-8.10M-10.84M-9.29M-7.58M-9.67M-11.04M-7.52M-7.72M-7.05M-26.22M-9.14M-6.26M-6.31M
Tax ProvisionsTaxes
2.75M1.39M-0.74M-2.11M-3.14M-2.26M-2.24M-2.11M3.83M0.02M0.02M0.02M-0.01M0.01M0.01M-1.17M-0.47M520.000.02M500.00
Income After Tax
7.50M11.71M-2.69M-1.36M-21.91M-5.76M-8.92M-5.98M-14.68M-9.31M-7.60M-9.70M-11.03M-7.53M-7.73M-5.89M-25.75M-9.14M-6.28M-6.31M
Equity Income
Income from Continuing OperationsIncome (Continuing)
7.50M11.71M-2.69M-1.36M-21.91M-5.76M-8.92M-5.98M-14.68M-9.31M-7.60M-9.70M-11.03M-7.53M-7.73M-5.89M-25.75M-9.14M-6.28M-6.31M
Consolidated Net IncomeConsol Net Inc.
7.50M11.71M-2.69M-1.36M-21.91M-5.58M-8.81M-5.95M-15.14M-9.23M-7.45M-9.66M-11.02M-7.62M-7.93M-5.93M-25.84M-9.14M-6.28M-6.31M
Net Income Attributable to Noncontrolling InterestsNCI Net Income
11.71M-2.69M-1.36M-21.61M0.18M0.11M0.03M0.08M0.14M0.04M
Income towards Parent CompanyParent Net Inc
7.50M11.71M-2.69M-1.36M-21.91M-5.76M-8.92M-5.98M-14.68M-9.31M-7.60M-9.70M-11.03M-7.53M-7.73M-5.89M-25.75M-9.14M-6.28M-6.31M
Net Income towards Common StockholdersNet Income
7.50M11.71M-2.69M-1.36M-21.91M-5.76M-8.92M-5.98M-14.68M-9.31M-7.60M-9.70M-11.03M-7.53M-7.73M-5.89M-25.75M-9.14M-6.28M-6.31M
Additional items
EPS (Basic)
0.260.35-0.08-0.04-0.70-0.20-0.31-0.20-0.50-0.31-0.25-0.32-0.36-0.24-0.23-0.16-19.35-4.06-1.46-1.01
EPS (Diluted)
0.250.34-0.08-0.04-0.70-0.20-0.31-0.20-0.50-0.31-0.25-0.32-0.36-0.24-0.23-0.16-19.35-4.06-1.46-1.01
Shares Outstanding
28.87M33.94M32.47M31.32M31.48M29.48M29.09M29.36M29.35M29.84M30.12M30.49M30.34M32.05M33.11M37.89M1.33M2.25M4.31M6.27M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
29.90M34.71M32.47M31.32M31.48M29.48M29.09M29.36M29.35M29.84M30.12M30.49M30.34M32.05M33.11M37.89M1.33M2.25M4.31M6.27M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
33.82M33.98M33.78M30.92M30.87M30.63M30.79M30.66M31.26M31.28M31.91M31.93M33.05M33.57M36.18M37.89M1.33M2.25M4.88M7.29M
EBITDA
10.41M10.07M-3.72M-6.22M-25.82M-9.63M-11.69M-8.64M-11.51M-9.93M-7.34M-9.88M-11.55M-8.27M-7.77M-6.75M-26.27M-8.95M-6.00M-6.05M
Interest ExpensesInt Expense
Tax Rate
26.80%10.58%

Co-Diagnostics Income Statement API

Pull Co-Diagnostics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CODX&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY